Novartis Investigative Site

Panama City, Republica de Panama 0801

0 studies enrolling now · 2 studies all time

What they study most

Sickle Cell Disease (SCD), Transfusion-dependent Anemia

Studies at this site

• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients — Running, not enrolling
• Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload — Completed